Trial reportJournal of the American College of Radiology : JACR2026
A Multilevel Approach to Improve Participation in Low-Dose CT for Lung Cancer Screening (Empower LCS): A Single-Arm Pilot Feasibility Clinical Trial.
Trial report in Journal of the American College of Radiology : JACR, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07711691 (Empowering Patients' Lung Cancer Screening Uptake), which is not on this map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Empowering Patients' Lung Cancer Screening Uptake (Empower LCS/Call+): A Multi-Site Pilot Randomized Controlled Trial
Who cites it
2 citing papers in PubMed.
- Analysis of Lung Cancer Screening Eligibility Among Patients Diagnosed With Lung Cancer: A Retrospective Cohort Study.Journal of the American College of Radiology : JACR · 2026Article
- Patients' and Providers' Perspective of a Multi-level Approach to Improve Participation in Low-dose CT for Lung Cancer Screening (Empower LCS): A Mixed-Methods Analysis.Academic radiology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
Abstract
backgroundLung cancer screening (LCS) uptake remains low nationally. We evaluated the feasibility and preliminary efficacy of a multilevel intervention to improve LCS uptake in a pilot trial.
methodsEligible patients were 50 to 80 and met 2021 United States Preventive Services Task Force LCS criteria. The Empower LCS intervention included (1) a decision aid; (2) a text reminder to encourage LCS discussion with primary care providers (PCPs); (3) PCP notifications on eligibility and barriers, and (4) financial hardship and health-related social needs support. Screening outcomes (LCS discussions, orders, and completion) at 6 months were assessed using medical records and surveys. Changes in LCS knowledge and health beliefs were assessed with surveys.
resultsIn all, 70 patients enrolled (mean age: 62.5 ± 6.3; 70% male; 1.4% Black, 18.6% Asian, 44.3% White, 35.7% other); 45.7% were Hispanic, and 41% were current smokers. Common LCS barriers included cost concerns (40%, 28 of 70) and fear of finding something wrong (34.3%, 24 of 70). All received the decision aid, text reminder, and PCP alert. Of the patients, 72.9% reported financial hardship or health-related social needs and received support. At 6 months, 71.4% (50 of 70) discussed LCS with their PCP, 51.4% (36 of 70) received low-dose CT orders, and 27.1% (19 of 70) completed screening (52.8% of those with order). Completion exceeded the national average of 16% (P = 0.01). Knowledge and perceived severity changed significantly (knowledge: from 1.91 to 2.67, P = .01; severity: from 16.3 to 18.1, P = .0003). No significant changes were observed in perceived barriers or self-efficacy.
conclusionThe Empower LCS intervention was feasible and improved LCS uptake. However, only half of those with LCS order, completed screening, suggesting the need for enhanced navigation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.